Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease

Atherosclerosis

Volumn 154, Issue 1, 2001, Pages 147-154

  Loehrer, Franziska M T ^a   Tschöpl, Martin ^b   Angst, Christian P ^a   Litynski, Piotr ^a   Jäger, Kurt ^b   Fowler, Brian ^a   Haefeli, Walter E ^b,c  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Erythrocy tes; High performance liquid chromatography; Homocysteine; Methylation; Peripheral arterial occlusive disease; S Adenosylhomocysteine; S Adenosylmethionine

Indexed keywords

S ADENOSYLHOMOCYSTEINE; S ADENOSYLMETHIONINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ERYTHROCYTE; FEMALE; HEMATOCRIT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METHYLATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ARTERIAL OCCLUSIVE DISEASES; ERYTHROCYTES; FEMALE; HEMATOCRIT; HOMOCYSTEINE; HUMANS; KIDNEY; MALE; MIDDLE AGED; ODDS RATIO; REFERENCE VALUES; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE;

EID: 0035200122     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(00)00449-4     Document Type: Article

References (41)

1. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease
2. Hyperhomocysteinaemia and endothelial dysfunction in peripheral arterial disease
3. Homocysteine and cardiovascular disease
4. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men
5. Plasma homocyst(e)ine: A risk factor for arterial occlusive diseases
6. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians
7. Plasma homocysteine and severity of atherosclerosis in young patients with lower-limb atherosclerotic disease
8. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment
9. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease
10. Plasma homocysteine as a risk factor for vascular disease: The European concerted action project
11. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
12. A relationship between homocysteine and thrombotic disease
13. Plasma homocysteine and cardiovascular disease
14. S-adenosylmethionine and methylation
15. Methionine metabolism in mammals
16. An abnormal methylation ratio induces hypomethylation in vitro in the brain of pig and man, but not in rat
17. Low whole blood S-adenosylmethionine and correlation between 5-methyltetrahydrofolate and homocysteine in coronary artery disease
18. Membrane protein damage and methylation reactions in chronic renal failure
19. Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine
20. Evidence for disturbed S-adenosylmethionine/S-adenosylhomocysteine ratio in patients with end-stage renal failure: A cause for disturbed methylation reactions
21. The effect of methionine loading on 5-methyltetrahydrofolate, S-adenosylmethionine and S-adenosylhomocysteine in plasma of healthy humans
22. The kidney in pre-clinical and clinical pharmacokinetics
23. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease
24. Hyperhomocyst(e)inaemia: An independent risk factor for intermittent claudication
25. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease
26. Putative mechanisms for vascular damage by homocysteine
27. Increased plasma homocysteine concentration in patients with chronic renal failure
28. Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes
29. Role of hemostatic risk factors for restenosis in peripheral arterial occlusive disease after transluminal angioplasty
30. Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia
31. Homocysteine production in chronic renal failure
32. The hemolytic activity of homocysteine is increased by the activated polymorphonuclear leukocytes
33. Disposition of homocysteine and S-3-deazaadenosyl-homocysteine in cells exposed to 3-deazaadenosine
34. Inborn errors of pterin metabolism
35. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease
36. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes
37. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population
38. Plasma homocysteine, a risk factor for cardiovascular disease is lowered by physiological doses of folic acid
39. Vitamins as homocysteine-lowering agents
40. Vitamin supplementation reduces blood homocysteine levels. A controlled trial in patients with venous thrombosis and healthy volunteers